Frexalimab Clinical Trials

2 actively recruiting trials across 2 locations

▼ -2 trials since May 2026

Also known as: SAR441344

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

Sanofi2

Indications

Type 1 Diabetes Mellitus1
Multiple Sclerosis1
Diabetes1

Cullman, Alabama1 trial

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

North Central Neurology Associates- Site Number : 8401100

Phase 3

San Francisco, California1 trial

FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)

University of California San Francisco - Mission Bay- Site Number : 8400012

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.